Share on StockTwits

Shares of Shire PLC (NASDAQ:SHPG) have received an average recommendation of “Buy” from the twenty brokerages that are covering the company, Stock Ratings Network.com reports. Nine investment analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $219.00.

A number of analysts have recently weighed in on SHPG shares. Analysts at Leerink Swann upgraded shares of Shire PLC from a “market perform” rating to an “outperform” rating in a research note on Monday, July 21st. They now have a $269.00 price target on the stock. Separately, analysts at Buckingham Research downgraded shares of Shire PLC from a “buy” rating to a “neutral” rating in a research note on Monday, July 21st. Finally, analysts at SunTrust downgraded shares of Shire PLC from a “buy” rating to a “neutral” rating in a research note on Monday, July 21st. They now have a $269.00 price target on the stock, up previously from $250.00.

Shares of Shire PLC (NASDAQ:SHPG) opened at 247.94 on Monday. Shire PLC has a 52-week low of $109.75 and a 52-week high of $258.55. The stock’s 50-day moving average is $235.2 and its 200-day moving average is $179.2. The company has a market cap of $48.464 billion and a price-to-earnings ratio of 44.13.

Shire PLC (NASDAQ:SHPG) last posted its quarterly earnings results on Friday, July 18th. The company reported $2.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.45 by $0.22. The company had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.45 billion. During the same quarter in the previous year, the company posted $1.79 earnings per share. The company’s revenue for the quarter was up 20.0% on a year-over-year basis. On average, analysts predict that Shire PLC will post $9.96 earnings per share for the current fiscal year.

Shire plc (NASDAQ:SHPG) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.